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Abstract
Introduction: Eisenmenger's syndrome in pregnancy can lead to death in 50% to 65% of
parturients. Expensive invasive monitoring and medication have improved management and
outcomes. Cheaper alternatives for the management of high-risk patients who present with no
prenatal care are still not available.
Case presentation: We describe the obstetric anaesthesia management of a 34-year-old, 34-
weeks pregnant woman who presented with a recent diagnosis of severe Eisenmenger's syndrome.
A combined spinal epidural anaesthesia was used together with invasive cardiac monitoring as well
as PGE1 nebulisation after delivery of the baby. This helped achieve a reduction of shunt,
improvement of hypoxia and reduction of pulmonary pressures.
Conclusion: We found this to be a cheaper and safe alternative in the management of such
patients who present with no adequate prior management.
Introduction
Eisenmenger's syndrome with pulmonary hypertension
and reversal of shunt can be a lethal condition when com-
bined with pregnancy. Chronic hypoxia, dyspnoea and
orthopnoea with severely diminished exercise tolerance as
well as right heart failure is often the pathology involved
with deterioration [1]. As pregnancy progresses the pul-
monary gradient worsens and shunt reversal increases.
Early literature seems to suggest that termination of preg-
nancy is the only option to save the parturient's life [2].
However, the recent literature reports successful preg-
nancy and delivery when the patient is managed with var-
ious modes including sildenafil and prostacyclin from
early gestation [3,4]. However, these are high-risk cases
that are managed from the first trimester onwards with
oral medication. There is, as yet, no description of patients
who present for delivery at full term with no management
with pulmonary antihypertensive agents and with a criti-
cal pulmonary gradient.
Case presentation
We present the anaesthetic management of a 34-year-old
gravida III, para 1 woman who was 34 weeks pregnant
and who presented to a University Hospital setting for
caesarean delivery. She was recently diagnosed with pul-
monary arterial hypertension (PAH) and atrial septal
defect (ASD). Her foetus was also diagnosed on a prenatal
ultrasound as having an ASD. She was also suffering from
gestational diabetes. Her clinical history included dysp-
noea at rest and orthopnoea requiring two pillows whilst
sleeping. She had a severely restricted functional capacity.
She had a previous uneventful caesarean section 4 years
prior as well as a miscarriage in the first trimester 3 years
prior. She admitted that her symptoms were much worse
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pansystolic murmur in the left apex. An echocardiogram
revealed a moderate sized ASD with severe PAH, moderate
pulmonary and tricuspid regurgitation and enlarged right
heart. A cardiology consultation recommended placing
her on oral furosemide, aspirin and potassium supple-
ments.
After counselling the patient and her family pre-opera-
tively in consultation with the obstetrician, the patient
was advised regional anaesthesia for the delivery. On the
day of the caesarean delivery, after routine monitors were
placed in the operating room, a radial arterial line was
placed for beat-to-beat blood pressure monitoring. Her
baseline saturation as revealed by the use of a pulse oxi-
meter was 89% to 95% on facemask oxygen. She was then
placed in a sitting position where a combined spinal epi-
dural technique was used to deliver a slow graded spinal
with 1 cc 0.5% bupivacaine and 20 mcg of fentanyl with a
27-gauge spinal needle. She was then placed in a semi-sit-
ting position at 45° propped up on pillows as much as her
orthopnoea would allow. Another 2 cc of 0.25% bupi-
vacaine was administered via the epidural catheter to
establish a block up to T4 level. A strong motor block was
accomplished. Systemic blood pressures were supported
by boluses of phenylephrine. Caesarean section was then
performed without delay in the semi-recumbent position
without event and the patient remained comfortable. A
pulmonary artery (PA) catheter was floated during surgery
to reveal PA pressures of 60 to 70 systolic. After delivery of
the baby, the patient was nebulised with 1 cc of prostacy-
cline (PGE1) and 4 cc of normal saline via a facemask for
30 minutes. Her arterial saturations improved to 99% and
PA pressures reduced to 30 to 40 systolic. Systemic blood
pressures were stable. The entire procedure lasted 1.2
hours with no untoward event and both mother and baby
remained well post-operatively. She was monitored in the
cardiac care unit for 24 hours and later sent to the ward.
She was discharged home on day seven with no problems.
She had refused a tubal ligation.
Discussion
Parturients from developing countries often present with
undiagnosed or recently worsening symptoms caused by
congenital cardiac anomalies. This leads to a higher
maternal and infant mortality rate in these countries [5].
Intermarriages also have an impact leading to a higher
incidence of such anomalies in these countries. Eisen-
menger's syndrome has a mortality rate of 50% to 65% [6]
in good centres where high-risk obstetric care is available.
Unfortunately many of these women die in early or mid-
pregnancy or during delivery due to the unavailability of
sophisticated monitoring or expensive drugs. Although
no one type of anaesthetic technique has been found to be
superior to any other, the use of general anaesthesia (GA)
in this case seemed more risky due to the fact that the
patient could not lie flat because of orthopnoea. GA can
lower the systemic vascular resistance (SVR) severely after
induction thereby worsening the right-to-left shunt in
such patients, making weaning off the ventilator and extu-
bation at the end of surgery difficult because of the poten-
tial worsening of oxygen saturation levels. Regional
anaesthesia can also lower the SVR ; however, a slow onset
can lower this effect in a predictable manner and thereby
reduce the right-to-left shunting. A graded spinal block is
a preferable alternative to epidural alone as this can
quickly ensure the faster motor block required for surgical
intervention and can lessen the time of SVR reduction in
total, as compared with an epidural infusion requiring
large volumes of medication to achieve the same block. In
addition, an epidural catheter can be put in place for post-
operative pain relief or in case the surgery is prolonged;
additional small boluses of local anaesthetic can also be
given to supplement the block intra-operatively in a more
graded manner via the catheter if required.
We chose the use of regional anaesthesia (combined spi-
nal epidural) with invasive cardiac monitoring in this
case, as well as, administration of nebulisation intra-oper-
atively with PGE1. This has previously been used selec-
tively to reduce shunting in adult respiratory distress
syndrome and to improve pulmonary hypertension [7].
Previous case reports and non-randomised studies have
indicated that inhalation of aerosolised PGE1 may offer a
new life-saving strategy in intractable pulmonary hyper-
tension [8,9]. Its use in the management of parturients has
not been described elsewhere in the literature.
Conclusion
We conclude that the use of nebulised alprostadil follow-
ing caesarean delivery in a parturient with severe pulmo-
nary hypertension and increased left-to-right shunt can be
performed safely, providing a better and more cost-effec-
tive outcome.
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